Prostate Cancer News and Research

Latest Prostate Cancer News and Research

New genetic test for prostate cancer

Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test.

18 Jan 2008

Cancer stem cell marker also drives transcription in normal cells

New research links the recently discovered function of a multi-faceted transcriptional complex to control of gene expression in both normal cells and cancer stem cells.

18 Jan 2008

Gene markers located for hereditary prostate cancer

Researchers at the Johns Hopkins Brady Urological Institute, Wake Forest University and the Karolinska Institute in Sweden have identified an array of gene markers for hereditary prostate cancer that, along with family history for the disease, appear to raise risk to more than nine times that of men without such markers.

17 Jan 2008

Cancer Research UK invests 10 million pounds in drug discovery

Project leaders at Imperial College London, University of Oxford, University of Strathclyde and The School of Pharmacy in London will each receive 500k pounds per year for five years to develop anti-cancer drugs.

17 Jan 2008

Hormonal nutritional supplements might speed prostate cancer progression

Hormonal components in over-the-counter dietary supplements may promote the progression of prostate cancer and decrease the effectiveness of anti-cancer drugs, researchers at UT Southwestern Medical Center have discovered.

16 Jan 2008

Hormonal components in over-the-counter dietary supplements might promote prostate cancer progression

15 Jan 2008

Researchers associate six new genetic variants with heart disease risk factor

Using new techniques for rapidly scanning the human genome, researchers have associated levels of cholesterol and triglycerides, two fats in the blood, to 18 genetic variants, six of which represent new DNA regions never before associated with the traits.

15 Jan 2008

Body's immune system uses common molecule to recognize prostate tumors

In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors.

11 Jan 2008

Morphotek announces agreement for development of antibodies to treat prostate cancer

Morphotek, Inc., a subsidiary of Eisai Co., Ltd., has announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the development of therapeutic antibodies to a cancer-associated protein identified by NCI researchers.

10 Jan 2008

Testosterone levels may affect men's cognitive performance

When we think about the powers of testosterone, we usually do not consider mental processes.

8 Jan 2008

Fatherhood may increase the risk of prostate cancer

Research by Danish scientists has found that fatherhood can increase a man's risk of developing prostate cancer.

8 Jan 2008

Racial disparities in cancer therapy still widespread

Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the January 7 online issue of the journal Cancer.

8 Jan 2008

Researchers say health benefits of sunshine outweigh the skin cancer risk and might help you live longer

According to a new study sunshine might help you live longer and for some people the health benefits possibly outweigh the skin cancer risk of skin cancer.

7 Jan 2008

Racial disparities persist in cancer care

A new study finds that, despite efforts in the last decade to mitigate cancer treatment disparities, black patients are significantly less likely than white patients to receive therapy for various types of cancer.

7 Jan 2008

Benefits of short-term hormonal therapy for men receiving radiation therapy for prostate cancer far outweigh the risks

Researchers report that just four months of hormonal therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years - especially the development of bone metastases - and increased survival in older men with potentially aggressive prostate cancer.

4 Jan 2008